|
Mesothelioma Articles
ALIMTA Plus Gemcitabine as Front-Line Chemotherapy for Patients with Malignant Pleural or Peritoneal Mesothelioma - Lung Cancer
June 23, 2004
The Purpose of the Trial
This clinical trial is for people who have advanced malignant pleural or peritoneal mesothelioma. The purpose of this trial is to see if the study drugs, alimta and gemcitabine, have any effect on your cancer. For example, will these drugs cause your tumor(s) to shrink or stop growing? The purpose is also to gather more information on how safe the drugs are in humans. This is a Phase II clinical trial. Phase II trials evaluate how well an experimental drug or drug combination works at treating the cancer. During this phase, researchers also test the safety of the drug and what side effects occur.
Description of the Trial
This trial involves taking two drugs called alimta and gemcitabine. Alimta is not FDA-approved. Therefore, it is considered to be experimental in this study. Study doctors hope to find out how this drug affects your body and your cancer. Gemcitabine is FDA-approved and is often used to treat your type of cancer.
Description of Study Treatment
If you are eligible and choose to participate, you will receive gemcitabine on days 1 and 8 of every cycle. One cycle is 21 days. You will also get alimta on day 8 (before gemcitabine) of every cycle. You can receive up to six cycles of chemotherapy depending on how you respond to the study treatment. While you¿re on this study, you could undergo blood tests and physical exams. You could also undergo CT scans so that the study doctors can measure the extent of your cancer.
Description of Study Treatment TimelineYour study treatment is expected to last as long as you benefit from the study drug for a maximum of 6 cycles. Participation in this trial will last for:· As long as your tumor responds and there are no serious side effects· Until you choose to withdraw
Contact Information
Brigham & Womans Hospital
Dana-Farber/Brigham & Women's
Hospital Cancer Center
1-866-790-4500
75 Francis Street, Boston, MA 02115, USA
Source: Brigham & Women's Hospital
| MIRG.org 1-888-802-6376 e-mail |  |
|
|
•
•
•
•
•
|
Mesothelioma Information
Resource Group, MIRG.org, tries to assist individuals and families in learning about mesothelioma and other asbestos related injuries. It is the aim of MIRG.org to provide an account of the disease mesothelioma, its causes, various treatment options and potential legal impact. To find out more about Mesothelioma and other asbestos related diseases, new medical advances, and clinical trials now available please use the links provided.
The information on this website is presented by the Mesothelioma Information Resource Group and is for informational purposes only.
No particular course of treatment is suggested. All persons are advised to consult with a medical doctor concerning treatment of
mesothelioma or any illness. Also, nothing on this website is intended to constitute legal advice by a lawyer or attorney. Note disclaimer.
|
